Literature DB >> 21344707

Risk adjustment and risk equalization: what needs to be done?

Wynand P M M Van de Ven1.   

Abstract

In this paper, we first deal with the rationale of risk adjustment and risk equalization in health insurance markets. Then we discuss the state of the art concerning the application of risk adjustment and risk equalization in practice. Finally, we focus on: What needs to be done?

Mesh：

Year:  2011        PMID： 21344707     DOI： 10.1017/s1744133110000319

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN： 1744-1331


  6 in total

1.  The HHS-HCC risk adjustment model for individual and small group markets under the Affordable Care Act.

Authors:  John Kautter; Gregory C Pope; Melvin Ingber; Sara Freeman; Lindsey Patterson; Michael Cohen; Patricia Keenan
Journal:  Medicare Medicaid Res Rev       Date:  2014-05-09

2.  Risk transfer formula for individual and small group markets under the Affordable Care Act.

Authors:  Gregory C Pope; Henry Bachofer; Andrew Pearlman; John Kautter; Elizabeth Hunter; Daniel Miller; Patricia Keenan
Journal:  Medicare Medicaid Res Rev       Date:  2014-09-05

3.  Examining unpriced risk heterogeneity in the Dutch health insurance market.

Authors:  A A Withagen-Koster; R C van Kleef; F Eijkenaar
Journal:  Eur J Health Econ       Date:  2018-04-18

4.  Choice of insurer for basic health insurance restricted by supplementary insurance.

Authors:  Daniëlle M I D Duijmelinck; Wynand P M M van de Ven
Journal:  Eur J Health Econ       Date:  2013-07-26

5.  "Managed competition" for Ireland? The single versus multiple payer debate.

Authors:  Misja Mikkers; Padhraig Ryan
Journal:  BMC Health Serv Res       Date:  2014-09-26       Impact factor: 2.655

6.  A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims.

Authors:  David E Wennberg; Sandra M Sharp; Gwyn Bevan; Jonathan S Skinner; Daniel J Gottlieb; John E Wennberg
Journal:  BMJ       Date:  2014-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.